Home › Trials › NCT06626360
Clinical trial Recruiting at 3 sites Observational Ages 18 and up

Identifying Malnutrition in Overweight Adults

Official title: SCreening fOr Malnutrition and Obesity in Patients With COVID-19 and Other Diseases

Run by HAN University of Applied Sciences · NCT06626360 · Data updated 2026-11-12

This study is trying to see if overweight adults can also be malnourished, especially those affected by COVID-19, and will create a simple tool to help doctors spot malnutrition in these patients.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment2000 (estimated)
SponsorHAN University of Applied Sciences
Academic / other
Locations3 sites (Amsterdam and 2 other locations)
StatusRecruiting
StartedOctober 2, 2024
Main results expectedApril 30, 2025
Study endsAugust 31, 2025
Registry record updatedNovember 8, 2024
Trial IDNCT06626360 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 years or older who are classified as overweight with a BMI of 25 kg/m² or higher.

Probably not a fit

Patients who are physically or mentally unable to participate, or those with severe cognitive disorders, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to explore the coexistence of malnutrition and obesity in adults, particularly in the context of COVID-19 and cancer outcomes. It will involve literature and database research to identify parameters linked to worse disease outcomes and will develop a simple screening tool for recognizing malnutrition in overweight patients. The study will assess nutritional status and dietary treatment in primary care settings, focusing on patients with COVID-19. The findings could help improve clinical practices and patient care.

Why it matters

Potential benefit: If successful, this study could lead to better identification and management of malnutrition in overweight patients, potentially improving health outcomes during COVID-19 and other diseases.

How similar studies have gone: While the approach of screening for malnutrition in overweight individuals is gaining attention, this specific combination of factors in relation to COVID-19 outcomes is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Age 18 years or older
* Overweight (BMI of 25 kg/m² or higher)

Exclusion Criteria:

* Physically or mentally unable to participate.
* Severe cognitive disorder or severe emotional instability, as assessed by the attending nurse or physician.
* Insufficient proficiency in the Dutch language to express themselves properly and no interpreter or assistant to help.
* Patient resides in a nursing or care home.

Where it's running

  • Olvg
    Amsterdam, Netherlands     Recruiting
  • Ziekenhuis Gelderse Vallei
    Ede, Netherlands     Recruiting
  • ErasmusMC
    Rotterdam, Netherlands     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Overweight and Obese Adults 8Malnutrition or Risk of Malnutrition 4
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.